[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Li et al., 2011 - Google Patents

Effects of COX-2 inhibitor NS-398 on IL-10 expression in rat fungal keratitis

Li et al., 2011

View HTML
Document ID
1362181409522651688
Author
Li N
Che C
Hu L
Lin J
Wang Q
Zhao G
Publication year
Publication venue
International Journal of Ophthalmology

External Links

Snippet

AIM To investigate the expression of interleukin-10 (IL-10) and the effect of NS-398 (COX-2 inhibitor) on the expression of IL-10 in fungal keratitis in rats, and analyze its effects on anti- fungus immunity. METHODS Ninety Wister rats were randomly divided into 3 groups. Group …
Continue reading at pmc.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)

Similar Documents

Publication Publication Date Title
Yamaguchi Inflammatory response in dry eye
Chen et al. Anti-sepsis protection of Xuebijing injection is mediated by differential regulation of pro-and anti-inflammatory Th17 and T regulatory cells in a murine model of polymicrobial sepsis
Yu et al. Neurokinin-1 receptor antagonism ameliorates dry eye disease by inhibiting antigen-presenting cell maturation and T helper 17 cell activation
Chauhan et al. Corneal lymphatics: role in ocular inflammation as inducer and responder of adaptive immunity
Dai et al. Intratracheal administration of adipose derived mesenchymal stem cells alleviates chronic asthma in a mouse model
Besirli et al. Inhibition of retinal detachment-induced apoptosis in photoreceptors by a small peptide inhibitor of the fas receptor
Kovoor et al. Role of inflammatory cells in pathophysiology and management of diabetic retinopathy
El Annan et al. Regulation of T-cell chemotaxis by programmed death-ligand 1 (PD-L1) in dry eye–associated corneal inflammation
Mittal et al. Mesenchymal stromal cells inhibit neutrophil effector functions in a murine model of ocular inflammation
Pflugfelder et al. Matrix metalloproteinase-9 in the pathophysiology and diagnosis of dry eye syndrome
Sadrai et al. PDE4 inhibition suppresses IL-17–associated immunity in dry eye disease
Moore et al. The inflammatory milieu associated with conjunctivalized cornea and its alteration with IL-1 RA gene therapy
Yin et al. Zinc oxide nanoparticles ameliorate collagen lattice contraction in human tenon fibroblasts
Kim et al. TSG-6 protects corneal endothelium from transcorneal cryoinjury in rabbits
Gupta et al. Mitomycin C: a promising agent for the treatment of canine corneal scarring
Li et al. Effects of COX-2 inhibitor NS-398 on IL-10 expression in rat fungal keratitis
Yuan et al. Toll-like receptors involved in the pathogenesis of experimental Candida albicans keratitis
Zhao et al. BMSC-derived exosomes regulate the Treg/Th17 balance through the miR-21-5p/TLR4/MyD88/NF-κB pathway to alleviate dry eye symptoms in mice
Keles et al. The ocular endothelin system: a novel target for the treatment of endotoxin-induced uveitis with bosentan
Jiang et al. Fosfenopril attenuates inflammatory response in diabetic dry eye models by inhibiting the TLR4/NF-κB/NLRP3 signaling pathway
CN101584686B (en) Application of sodium valproate during preparing medicament for treating retina disease
Ling et al. Allograft survival enhancement using doxycycline in alkali‐burned mouse corneas
Shao et al. Infiltration of the inflamed eye by NKT cells in a rat model of experimental autoimmune uveitis
Wang et al. Interleukin-17 receptor E and CC motif chemokine receptor 10 identify heterogeneous T helper 17 subsets in a mouse dry eye disease model
Liang et al. Effect of blocking the OX40/OX40L signaling pathway by siRNA interference on animal experimental study of allergic rhinitis